Taro NonSpil
This article was originally published in The Tan Sheet
Executive Summary
Recent in-store demonstrations at Wal-Mart of Taro Pharmaceuticals' NonSpil drug delivery system were "met with huge and great reception from consumers," CFO Kevin Connelly comments at CIBC World Markets Healthcare Conference in New York City Nov. 12. Firm may conduct more demonstrations in Wal-Mart stores later this year or early next year, Connelly says. Taro is working on licensing agreements for NonSpil, the exec reports, adding that the firm will "have more growth opportunity...to license it on the prescription side" as possibility to extend the patent life of Rx drugs (1"The Tan Sheet" Sept. 15, 2003, p. 4). Sales of Taro's ElixSure line of cough/cold medicines for children, which was shipped in June and uses the NonSpil technology, are doing "very well," though "it is too early to tell" if the launch is a complete success, according to Connelly...